Organ Rejection Prophylaxis Archives - Page 6 of 6 - MPR

Organ Rejection Prophylaxis

Drug Class Linked to Worse Outcomes After Transplant

Drug Class Linked to Worse Outcomes After Transplant

Kidney transplant patients who receive mammalian target of rapamycin (mTOR) inhibitors after transplant have a greater probability of death or transplant failure than patients receiving calcineurin inhibitors.